Product Browser

Last updated: 2017/5/28

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

EIF4EBP2 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00001979-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-EIF4EBP2 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 13.31
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-EIF4EBP2 antibody (H00001979-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00001979-T01
    EIF4EBP2 transfected lysate.
    Western Blot
    QC Testing of H00001979-T01
    Lane 1: EIF4EBP2 transfected lysate ( 13.31 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 1979
  • Gene Name:
  • EIF4EBP2
  • Gene Alias:
  • 4EBP2,PHASII
  • Gene Description:
  • eukaryotic translation initiation factor 4E binding protein 2
  • Gene Summary:
  • This gene encodes a member of the eukaryotic translation initiation factor 4E binding protein family. The gene products of this family bind eIF4E and inhibit translation initiation. However, insulin and other growth factors can release this inhibition via a phosphorylation-dependent disruption of their binding to eIF4E. Regulation of protein production through these gene products have been implicated in cell proliferation, cell differentiation and viral infection. [provided by RefSeq
  • Other Designations:
  • OTTHUMP00000019756,phosphorylated, heat and acid stable regulated by insulin protein II
  • RSS
  • YouTube
  • Linkedin
  • Facebook